187 related articles for article (PubMed ID: 8740606)
1. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
[TBL] [Abstract][Full Text] [Related]
2. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
Jørum E; Warncke T; Stubhaug A
Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
[TBL] [Abstract][Full Text] [Related]
3. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
4. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery.
Stubhaug A; Breivik H; Eide PK; Kreunen M; Foss A
Acta Anaesthesiol Scand; 1997 Oct; 41(9):1124-32. PubMed ID: 9366932
[TBL] [Abstract][Full Text] [Related]
5. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
Warncke T; Stubhaug A; Jørum E
Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
[TBL] [Abstract][Full Text] [Related]
6. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study.
Backonja M; Arndt G; Gombar KA; Check B; Zimmermann M
Pain; 1994 Jan; 56(1):51-57. PubMed ID: 8159441
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of ketamine and lidocaine on spontaneous and mechanical evoked pain in patients with nerve injury pain.
Gottrup H; Bach FW; Juhl G; Jensen TS
Anesthesiology; 2006 Mar; 104(3):527-36. PubMed ID: 16508401
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
[TBL] [Abstract][Full Text] [Related]
9. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
Pöyhiä R; Vainio A
Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
[TBL] [Abstract][Full Text] [Related]
10. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients.
Graven-Nielsen T; Kendall SA; Henriksson KG; Bengtsson M; Sörensen J; Johnson A; Gerdle B; Arendt-Nielsen L
Pain; 2000 Apr; 85(3):483-491. PubMed ID: 10781923
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
12. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral ketamine on secondary hyperalgesia, thermal and mechanical pain thresholds, and sedation in humans.
Mikkelsen S; Jørgensen H; Larsen PS; Brennum J; Dahl JB
Reg Anesth Pain Med; 2000; 25(5):452-8. PubMed ID: 11009229
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain.
Webster LR; Walker MJ
Am J Ther; 2006; 13(4):300-5. PubMed ID: 16858163
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-dose intranasal (S)-ketamine in patients with neuropathic pain.
Huge V; Lauchart M; Magerl W; Schelling G; Beyer A; Thieme D; Azad SC
Eur J Pain; 2010 Apr; 14(4):387-94. PubMed ID: 19733106
[TBL] [Abstract][Full Text] [Related]
16. Intradermal administration of magnesium sulphate and magnesium chloride produces hypesthesia to mechanical but hyperalgesia to heat stimuli in humans.
Ushida T; Iwatsu O; Shimo K; Tetsunaga T; Ikeuchi M; Ikemoto T; Arai YC; Suetomi K; Nishihara M
J Neuroinflammation; 2009 Aug; 6():25. PubMed ID: 19715604
[TBL] [Abstract][Full Text] [Related]
17. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine.
Finch PM; Knudsen L; Drummond PD
Pain; 2009 Nov; 146(1-2):18-25. PubMed ID: 19703730
[TBL] [Abstract][Full Text] [Related]
18. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo.
Eide PK; Jørum E; Stubhaug A; Bremnes J; Breivik H
Pain; 1994 Sep; 58(3):347-354. PubMed ID: 7838584
[TBL] [Abstract][Full Text] [Related]
19. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
[TBL] [Abstract][Full Text] [Related]
20. Ketamine for pain: an update of uses in palliative care.
Prommer EE
J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
